BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Technolas Perfect Vision Receives FDA Approval of Latest Technology for Custom LASIK


3/15/2011 6:42:04 AM

MUNICH, GERMANY--(Marketwire - 03/14/11) - Technolas Perfect Vision GmbH (TPV), a cataract and refractive laser company at the forefront of providing advanced eye laser treatments, today announced that the U.S. Food and Drug Administration (FDA) has approved the ZYOPTIX® Advanced Nomogram. The Advanced Nomogram is the latest, state-of-the-art methodology for use in custom LASIK eye surgery procedures when treating nearsightedness and astigmatism. This confirms that "there is convincing evidence that LASIK myopia corrections are more accurate with the Advanced Nomogram than without it." Using the Advanced Nomogram when performing custom LASIK with the TECHNOLAS 217z100 laser, significantly improves the predictability of the results, as well as reducing the possibility of requiring a second enhancement procedure. Technolas Perfect Vision is the ONLY company in the US able to offer this latest, approved technology for LASIK on their laser platform. The Advanced Nomogram was developed in collaboration with the Center for Visual Science, at the University of Rochester Flaum Eye Institute. The research team from the University of Rochester which developed the Advanced Nomogram was led by Dr Scott M. MacRae, a leading international refractive surgeon. According to Dr MacRae, "The results achieved using the Advanced Nomogram set a new vision quality and accuracy benchmark in LASIK surgery in the US."

Visit www.ready4lasik.com to learn more about the availability of this new approach.

About Technolas Perfect Vision GmbH

Technolas Perfect Vision GmbH (TPV) is a leading ophthalmology laser company, formed through a joint venture between Bausch + Lomb, and 20/10 Perfect Vision AG. TPV has a full range of expertise in both femtosecond and excimer businesses, with current innovations focused on laser cataract surgery and the correction of presbyopia. More company information is available at www.technolaspv.com

®/™ denote trademarks of Technolas Perfect Vision GmbH. Contact:

News Media Contact: Lindsay Brooks Email: Email Contact

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES